A buffer solution is comprised of a weak conjugate acid-base pair, for example, a weak acid and its conjugate base, or a weak base and its conjugate acid. Small quantities of other acids or bases are neutralized when added to the solution, and as a result, the solution resists changes in pH. Solutions with stable pH are required for the processing of protein-based biologic APIs because of their sensitivity to changes in pH. The stable pH range and capacity (the amount of acid/base that can be added without a change in pH) of a buffer are determined by the conjugate acid-base pair.
Most purification steps for downstream processing of biologics require buffers to equilibrate, condition, wash, elute, or concentrate the product. They are used in product isolation and purification steps to facilitate protein capture and polishing and also in the filtration process for the removal of viruses or depyrogenation. Aqueous solutions are also required for cleaning and disinfecting downstream processing equipment, such as chromatography matrices and membrane filtration systems. The main equipment involved in downstream processing with buffers includes mixers for buffer preparation, as well as equipment for purification, including packed-bed chromatography systems, fluidized beds, ultrafiltration and diafiltration membranes, microfiltration membranes, depth filtration cartridges, and virus-removal systems.
The global Bio Pharma Buffer market is projected to grow from US$ 907.1 million in 2024 to US$ 1376.7 million by 2030, at a Compound Annual Growth Rate (CAGR) of 7.2% during the forecast period.
The key players are Avantor, Alfa Aesar (Thermo Fisher), Merck, Lonza, Bio-Rad, BD, GE, Healthcare, Promega Corporation, Hamilton Company, XZL BIO-TECHNOLOGY, SRL and so on. According to the revenue of these companies, we can know that the Bio Pharma Buffer industry is relative concentrated. Because the top 6 companies have more than 70% market share.
Report Covers:
This report presents an overview of global market for Bio Pharma Buffer, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Bio Pharma Buffer, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Bio Pharma Buffer, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Bio Pharma Buffer sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Bio Pharma Buffer market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Bio Pharma Buffer sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Merck
Lonza
Bio-Rad
BD
GE Healthcare
Promega Corporation
Hamilton Company
XZL BIO-TECHNOLOGY
SRL
Segment by Type
Phosphates Type
Acetates Type
TRIS Type
Others
Segment by Application
Research Institution
Pharmaceutical Industry
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Bio Pharma Buffer in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Bio Pharma Buffer manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bio Pharma Buffer sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Bio Pharma Buffer Product Introduction
1.2 Market by Type
1.2.1 Global Bio Pharma Buffer Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Phosphates Type
1.2.3 Acetates Type
1.2.4 TRIS Type
1.2.5 Others
1.3 Market by Application
1.3.1 Global Bio Pharma Buffer Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Research Institution
1.3.3 Pharmaceutical Industry
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Bio Pharma Buffer Sales Estimates and Forecasts 2019-2030
2.2 Global Bio Pharma Buffer Revenue by Region
2.2.1 Global Bio Pharma Buffer Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Bio Pharma Buffer Revenue by Region (2019-2024)
2.2.3 Global Bio Pharma Buffer Revenue by Region (2025-2030)
2.2.4 Global Bio Pharma Buffer Revenue Market Share by Region (2019-2030)
2.3 Global Bio Pharma Buffer Sales Estimates and Forecasts 2019-2030
2.4 Global Bio Pharma Buffer Sales by Region
2.4.1 Global Bio Pharma Buffer Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Bio Pharma Buffer Sales by Region (2019-2024)
2.4.3 Global Bio Pharma Buffer Sales by Region (2025-2030)
2.4.4 Global Bio Pharma Buffer Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Bio Pharma Buffer Sales by Manufacturers
3.1.1 Global Bio Pharma Buffer Sales by Manufacturers (2019-2024)
3.1.2 Global Bio Pharma Buffer Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Bio Pharma Buffer in 2023
3.2 Global Bio Pharma Buffer Revenue by Manufacturers
3.2.1 Global Bio Pharma Buffer Revenue by Manufacturers (2019-2024)
3.2.2 Global Bio Pharma Buffer Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Bio Pharma Buffer Revenue in 2023
3.3 Global Key Players of Bio Pharma Buffer, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Bio Pharma Buffer Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Bio Pharma Buffer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Bio Pharma Buffer, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Bio Pharma Buffer, Product Offered and Application
3.8 Global Key Manufacturers of Bio Pharma Buffer, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Bio Pharma Buffer Sales by Type
4.1.1 Global Bio Pharma Buffer Historical Sales by Type (2019-2024)
4.1.2 Global Bio Pharma Buffer Forecasted Sales by Type (2025-2030)
4.1.3 Global Bio Pharma Buffer Sales Market Share by Type (2019-2030)
4.2 Global Bio Pharma Buffer Revenue by Type
4.2.1 Global Bio Pharma Buffer Historical Revenue by Type (2019-2024)
4.2.2 Global Bio Pharma Buffer Forecasted Revenue by Type (2025-2030)
4.2.3 Global Bio Pharma Buffer Revenue Market Share by Type (2019-2030)
4.3 Global Bio Pharma Buffer Price by Type
4.3.1 Global Bio Pharma Buffer Price by Type (2019-2024)
4.3.2 Global Bio Pharma Buffer Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Bio Pharma Buffer Sales by Application
5.1.1 Global Bio Pharma Buffer Historical Sales by Application (2019-2024)
5.1.2 Global Bio Pharma Buffer Forecasted Sales by Application (2025-2030)
5.1.3 Global Bio Pharma Buffer Sales Market Share by Application (2019-2030)
5.2 Global Bio Pharma Buffer Revenue by Application
5.2.1 Global Bio Pharma Buffer Historical Revenue by Application (2019-2024)
5.2.2 Global Bio Pharma Buffer Forecasted Revenue by Application (2025-2030)
5.2.3 Global Bio Pharma Buffer Revenue Market Share by Application (2019-2030)
5.3 Global Bio Pharma Buffer Price by Application
5.3.1 Global Bio Pharma Buffer Price by Application (2019-2024)
5.3.2 Global Bio Pharma Buffer Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Bio Pharma Buffer Market Size by Type
6.1.1 US & Canada Bio Pharma Buffer Sales by Type (2019-2030)
6.1.2 US & Canada Bio Pharma Buffer Revenue by Type (2019-2030)
6.2 US & Canada Bio Pharma Buffer Market Size by Application
6.2.1 US & Canada Bio Pharma Buffer Sales by Application (2019-2030)
6.2.2 US & Canada Bio Pharma Buffer Revenue by Application (2019-2030)
6.3 US & Canada Bio Pharma Buffer Market Size by Country
6.3.1 US & Canada Bio Pharma Buffer Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Bio Pharma Buffer Sales by Country (2019-2030)
6.3.3 US & Canada Bio Pharma Buffer Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Bio Pharma Buffer Market Size by Type
7.1.1 Europe Bio Pharma Buffer Sales by Type (2019-2030)
7.1.2 Europe Bio Pharma Buffer Revenue by Type (2019-2030)
7.2 Europe Bio Pharma Buffer Market Size by Application
7.2.1 Europe Bio Pharma Buffer Sales by Application (2019-2030)
7.2.2 Europe Bio Pharma Buffer Revenue by Application (2019-2030)
7.3 Europe Bio Pharma Buffer Market Size by Country
7.3.1 Europe Bio Pharma Buffer Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Bio Pharma Buffer Sales by Country (2019-2030)
7.3.3 Europe Bio Pharma Buffer Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Bio Pharma Buffer Market Size
8.1.1 China Bio Pharma Buffer Sales (2019-2030)
8.1.2 China Bio Pharma Buffer Revenue (2019-2030)
8.2 China Bio Pharma Buffer Market Size by Application
8.2.1 China Bio Pharma Buffer Sales by Application (2019-2030)
8.2.2 China Bio Pharma Buffer Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Bio Pharma Buffer Market Size by Type
9.1.1 Asia Bio Pharma Buffer Sales by Type (2019-2030)
9.1.2 Asia Bio Pharma Buffer Revenue by Type (2019-2030)
9.2 Asia Bio Pharma Buffer Market Size by Application
9.2.1 Asia Bio Pharma Buffer Sales by Application (2019-2030)
9.2.2 Asia Bio Pharma Buffer Revenue by Application (2019-2030)
9.3 Asia Bio Pharma Buffer Sales by Region
9.3.1 Asia Bio Pharma Buffer Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Bio Pharma Buffer Revenue by Region (2019-2030)
9.3.3 Asia Bio Pharma Buffer Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Bio Pharma Buffer Market Size by Type
10.1.1 Middle East, Africa and Latin America Bio Pharma Buffer Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Bio Pharma Buffer Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Bio Pharma Buffer Market Size by Application
10.2.1 Middle East, Africa and Latin America Bio Pharma Buffer Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Bio Pharma Buffer Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Bio Pharma Buffer Sales by Country
10.3.1 Middle East, Africa and Latin America Bio Pharma Buffer Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Bio Pharma Buffer Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Bio Pharma Buffer Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Avantor
11.1.1 Avantor Company Information
11.1.2 Avantor Overview
11.1.3 Avantor Bio Pharma Buffer Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Avantor Bio Pharma Buffer Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Avantor Recent Developments
11.2 Alfa Aesar (Thermo Fisher)
11.2.1 Alfa Aesar (Thermo Fisher) Company Information
11.2.2 Alfa Aesar (Thermo Fisher) Overview
11.2.3 Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Alfa Aesar (Thermo Fisher) Recent Developments
11.3 Merck
11.3.1 Merck Company Information
11.3.2 Merck Overview
11.3.3 Merck Bio Pharma Buffer Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Merck Bio Pharma Buffer Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Merck Recent Developments
11.4 Lonza
11.4.1 Lonza Company Information
11.4.2 Lonza Overview
11.4.3 Lonza Bio Pharma Buffer Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Lonza Bio Pharma Buffer Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Lonza Recent Developments
11.5 Bio-Rad
11.5.1 Bio-Rad Company Information
11.5.2 Bio-Rad Overview
11.5.3 Bio-Rad Bio Pharma Buffer Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Bio-Rad Bio Pharma Buffer Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Bio-Rad Recent Developments
11.6 BD
11.6.1 BD Company Information
11.6.2 BD Overview
11.6.3 BD Bio Pharma Buffer Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 BD Bio Pharma Buffer Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 BD Recent Developments
11.7 GE Healthcare
11.7.1 GE Healthcare Company Information
11.7.2 GE Healthcare Overview
11.7.3 GE Healthcare Bio Pharma Buffer Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 GE Healthcare Bio Pharma Buffer Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 GE Healthcare Recent Developments
11.8 Promega Corporation
11.8.1 Promega Corporation Company Information
11.8.2 Promega Corporation Overview
11.8.3 Promega Corporation Bio Pharma Buffer Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Promega Corporation Bio Pharma Buffer Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Promega Corporation Recent Developments
11.9 Hamilton Company
11.9.1 Hamilton Company Company Information
11.9.2 Hamilton Company Overview
11.9.3 Hamilton Company Bio Pharma Buffer Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Hamilton Company Bio Pharma Buffer Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Hamilton Company Recent Developments
11.10 XZL BIO-TECHNOLOGY
11.10.1 XZL BIO-TECHNOLOGY Company Information
11.10.2 XZL BIO-TECHNOLOGY Overview
11.10.3 XZL BIO-TECHNOLOGY Bio Pharma Buffer Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 XZL BIO-TECHNOLOGY Bio Pharma Buffer Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 XZL BIO-TECHNOLOGY Recent Developments
11.11 SRL
11.11.1 SRL Company Information
11.11.2 SRL Overview
11.11.3 SRL Bio Pharma Buffer Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 SRL Bio Pharma Buffer Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 SRL Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Bio Pharma Buffer Industry Chain Analysis
12.2 Bio Pharma Buffer Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Bio Pharma Buffer Production Mode & Process
12.4 Bio Pharma Buffer Sales and Marketing
12.4.1 Bio Pharma Buffer Sales Channels
12.4.2 Bio Pharma Buffer Distributors
12.5 Bio Pharma Buffer Customers
13 Market Dynamics
13.1 Bio Pharma Buffer Industry Trends
13.2 Bio Pharma Buffer Market Drivers
13.3 Bio Pharma Buffer Market Challenges
13.4 Bio Pharma Buffer Market Restraints
14 Key Findings in The Global Bio Pharma Buffer Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Avantor
Alfa Aesar (Thermo Fisher)
Merck
Lonza
Bio-Rad
BD
GE Healthcare
Promega Corporation
Hamilton Company
XZL BIO-TECHNOLOGY
SRL
听
听
*If Applicable.